MSTN and Huntington disease: In particular, among them, Activin A, which shares the receptor with Mstn (i.e. ActRIIB) and has been related with muscle loss in cancer, seems worthy of being investigated as an additional biomarker of muscle wasting, also in HD patients [31, 32].